Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-10-11
1981-08-25
Love, Ethel G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260239BB, 2603403, 2603405R, 424278, 424282, A61K 3133, A61K 3136, A61K 31335, C07D22316
Patent
active
042859387
ABSTRACT:
New 7,8-dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines having pharmaceutical activity together with new intermediates and methods of synthesis for preparing them. The lead compound is 6-chloro-7,8-dihydroxy-1-(p-sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzaz epine which has very potent renal dopaminergic activity.
REFERENCES:
patent: 3496166 (1970-02-01), Mall et al.
patent: 3906006 (1975-09-01), Brossi et al.
patent: 4104379 (1978-08-01), Gallagher, Jr. et al.
patent: 4160765 (1979-07-01), Weinstock
patent: 4160766 (1979-07-01), Bream
patent: 4171359 (1979-10-01), Weinstock
Edgerton William H.
Foggio Richard D.
Lourie Alan D.
Love Ethel G.
SmithKline Corporation
LandOfFree
7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzaze does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzaze, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzaze will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1158433